BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 6376025)

  • 21. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
    Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?
    Reaven GM; Chen YI; Coulston AM; Greenfield MS; Hollenbeck C; Lardinois C; Liu G; Schwartz H
    Am J Med; 1983 Nov; 75(5B):85-93. PubMed ID: 6369971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity.
    Calles-Escandon J; Jaspan J; Robbins DC
    Diabetes Care; 1989; 12(10):709-14. PubMed ID: 2693010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the insulin resistance of patients with noninsulin-dependent diabetes mellitus secondary to insulin deficiency?
    Reaven GM; Chen YD; Moore JG; Hollenbeck CB
    Horm Metab Res; 1986 Apr; 18(4):244-6. PubMed ID: 3519411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From obesity to type 2 diabetes.
    Scheen AJ
    Acta Clin Belg Suppl; 1992; 14():30-6. PubMed ID: 1604959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
    Haffner SM; Miettinen H; Gaskill SP; Stern MP
    Diabetes; 1995 Dec; 44(12):1386-91. PubMed ID: 7589843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.
    Ferrannini E
    Endocr Rev; 1998 Aug; 19(4):477-90. PubMed ID: 9715376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What therapy do our NIDDM patients need? Insulin releasers.
    Crepaldi G; Del Prato S
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S159-65. PubMed ID: 8529509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducement by fat feeding of basal hyperglycemia in rats with abnormal beta-cell function. Model for study of etiology and pathogenesis of NIDDM.
    Pascoe WS; Storlien LH
    Diabetes; 1990 Feb; 39(2):226-33. PubMed ID: 2146180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM).
    Beck-Nielsen H; Henriksen JE; Vaag A; Hother-Nielsen O
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S13-25. PubMed ID: 8529505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):79-85. PubMed ID: 1316330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.
    Halter JB; Ward WK; Porte D; Best JD; Pfeifer MA
    Am J Med; 1985 Aug; 79(2B):6-12. PubMed ID: 2863979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
    Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.